Pharmacogenetics: global clinical markers

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.9, Iss.4, 2008-04, pp. : 371-373

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pharmacogenetics of controlled ovarian hyperstimulation: time to corroborate the clinical utility of FSH receptor genetic markers

By Morón Francisco Jesús Ruiz Agustín

Pharmacogenomics, Vol. 11, Iss. 11, 2010-11 ,pp. : 1613-1618

Future Medicine

Access to resources Recommend Favorite

Clinical pharmacology and pharmacogenetics of gemcitabine

By Wong Andrea Soo Ross A. Yong Wei-Peng Innocenti Federico

Drug Metabolism Reviews, Vol. 41, Iss. 2, 2009-05 ,pp. : 77-88

Informa Healthcare

Access to resources Recommend Favorite

Clinical applications of pharmacogenetics in psychiatry

By Staddon Susan Arranz Maria Mancama Dalu Mata I. Kerwin Robert

Psychopharmacology, Vol. 162, Iss. 1, 2002-06 ,pp. : 18-23

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacogenetics of clinical response to risperidone

By LLerena Adrián Berecz Roland Peñas-LLedó Eva Süveges Ágnes Fariñas Humberto

Pharmacogenomics, Vol. 14, Iss. 2, 2013-01 ,pp. : 177-194

Future Medicine

Access to resources Recommend Favorite

Clinical Pharmacogenetics of Methotrexate

Current Drug Metabolism, Vol. 12, Iss. 3, 2011-03 ,pp. : 278-286

Bentham Science Publishers

Access to resources Recommend Favorite